
Higher ImP Levels Linked to Alzheimer’s-Linked Brain Changes
The story in brief
Research from the University of Wisconsin–Madison, published on October 3, links higher imidazole propionate (ImP) levels in the blood to brain changes associated with Alzheimer’s. Mice exposed to ImP developed Alzheimer’s-like features, while higher ImP levels correlated with poorer cognitive test performance. The study highlights the gut-brain connection but notes probiotics’ varied effects and no direct link to Alzheimer’s risk reduction.